HANLY ANN M.
SEC insider (Form 3/4/5 filer). CIK 0001854528. EVP & Chief Technology Officer at Vir Biotechnology, Inc. (VIR). 1 reported Form 4/5 transaction since Sep 2024; latest on Feb 24, 2025. Located in SAN FRANCISCO, CA.
Companies HANLY ANN M. has filed insider reports for
- Vir Biotechnology, Inc. (VIR): Officer, EVP & Chief Technology Officer
HANLY ANN M.
CIK: 0001854528
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (100.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VIR
Vir Biotechnology, Inc.
Officer